Xenetic Biosciences Inc expected to post a loss of 87 cents a share - Earnings Preview

Xenetic Biosciences

19/03/2024 13:14

* Xenetic Biosciences Inc  XBIO.OQ   XBIO.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 21
(estimated) for the period ending December 31 2023
    * The Framingham Massachusetts-based  company is expected to
report a 39.9% increase in revenue to $680 thousand from $486
thousand a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Xenetic Biosciences Inc
is for
a loss of 87 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated March 19 at 13:14 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)